The Physiological Effects of Pacing on Catheter Ablation Procedures to Treat Atrial Fibrillation (PEP AF)
Brief description of study
The purpose of this study is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to severely active Crohn's disease (CD).
Clinical Study Identifier: s16-00813
ClinicalTrials.gov Identifier: NCTs16-00813
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
